missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
STEMCELL Technologies Everolimus
Beskrivelse
- Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR)
- It is a hydroxyethyl ether-substituted derivative of rapamycin with improved pharmacokinetic and pharmacodynamic properties
- It inhibits both mTORC1 and mTORC2 complexes by binding to FK506-binding protein (FKBP-12), which then binds to mTOR, leading to complex destabilization and blocked kinase function (Zeng et al.; Lebwohl et al.; Sedrani et al.; Huang & Houghton)
- Inhibits cell proliferation, metabolism, and angiogenesis in a variety of cancers using in vitro and in vivo models (Zhu et al.; Lane et al.; O'Reilly et al.; Lebwohl et al.)
- Acts as an immunosuppressive agent in the context of organ transplantation (Lebwohl et al.; Wullschleger et al.)
Tekniske data
Tekniske data
| CAS | 159351-69-6 |
| Synonym | RAD001; SDZ-RAD; Xience |
| Mængde | 25 mg |
| Molekylær formel | C53H83NO14 |
| Renhed | ≥95% |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?